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Oligomerization of Fusogenic Peptides Promotes Membrane Fusion by
Enhancing Membrane Destabilization
Abstract
A key element of membrane fusion reactions in biology is the involvement of specific fusion proteins. In many
viruses, the proteins that mediate membrane fusion usually exist as homotrimers. Furthermore, they contain
extended triplehelical coiled-coil domains and fusogenic peptides. It has been suggested that the coiled-coil
domains present the fusogenic peptide in a conformation or geometry favorable for membrane fusion. To test
the hypothesis that trimerization of fusogenic peptide is related to optimal fusion, we have designed and
synthesized a triple-stranded coiled-coil X31 peptide, also known as the ccX31, which mimics the influenza
virus hemagglutinin fusion peptide in the fusion-active state. We compared the membrane interactive
properties of ccX31 versus the monomeric X31 fusogenic peptide. Our data show that trimerization enhances
peptide-induced leakage of liposomal contents and lipid mixing. Furthermore, studies using micropipette
aspiration of single vesicles reveal that ccX31 decreases lysis tension, τlysis, but not area expansion modulus,
Ka, of phospholipid bilayers, whereas monomeric X31 peptide lowers both τlysis and Ka. Our results are
consistent with the hypothesis that oligomerization of fusogenic peptide promotes membrane fusion, possibly
by enhancing localized destabilization of lipid bilayers.
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Oligomerization of Fusogenic Peptides Promotes Membrane Fusion by
Enhancing Membrane Destabilization
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ABSTRACT A key element of membrane fusion reactions in biology is the involvement of speciﬁc fusion proteins. In many
viruses, the proteins that mediate membrane fusion usually exist as homotrimers. Furthermore, they contain extended triple-
helical coiled-coil domains and fusogenic peptides. It has been suggested that the coiled-coil domains present the fusogenic
peptide in a conformation or geometry favorable for membrane fusion. To test the hypothesis that trimerization of fusogenic
peptide is related to optimal fusion, we have designed and synthesized a triple-stranded coiled-coil X31 peptide, also known as
the ccX31, which mimics the inﬂuenza virus hemagglutinin fusion peptide in the fusion-active state. We compared the
membrane interactive properties of ccX31 versus the monomeric X31 fusogenic peptide. Our data show that trimerization
enhances peptide-induced leakage of liposomal contents and lipid mixing. Furthermore, studies using micropipette aspiration
of single vesicles reveal that ccX31 decreases lysis tension, tlysis, but not area expansion modulus, Ka, of phospholipid
bilayers, whereas monomeric X31 peptide lowers both tlysis and Ka. Our results are consistent with the hypothesis that
oligomerization of fusogenic peptide promotes membrane fusion, possibly by enhancing localized destabilization of lipid
bilayers.
INTRODUCTION
Membrane fusion reactions are involved in many important
biological processes, such as transmission of neurotransmit-
ters across synapses, fertilization, intracellular trafficking,
recycling of membrane components, and fusion of enveloped
viruses with host cells (Brunger, 2001; Eckert and Kim,
2001; Hernandez et al., 1996; Jahn and Sudhof, 1999; White,
1992). For the most part, lipid bilayers and membranes do
not spontaneously achieve contact or fusion because strong
electrostatic, hydration, and steric repulsion forces present
large energetic barriers (Chernomordik et al., 1987; Helm
et al., 1992; Israelachvili et al., 1980; Rand and Parsegian,
1986). In biological systems, these barriers are believed to be
overcome by proteins that mediate fusion. To date, many
fusion proteins and candidate fusion proteins have been
identified (Glabe, 1985; Primakoff et al., 1987; Saginario
et al., 1995; Sutton et al., 1998; Trueheart and Fink, 1989;
Yagami-Hiromasa et al., 1995).
Of all the fusion systems, the entry of an enveloped virus
into the host is considered the simplest membrane fusion
reaction because it does not involve mixing of lipid bilayers
between distinct subcellular compartments. Thus, it has long
been held that the viral entry process may serve as a model
system for the more complicated intracellular trafficking
processes. Despite dissimilarities among enveloped viruses,
viral fusion proteins share a number of common features.
Many of them are synthesized as a single polypeptide chain
that becomes fusion-capable after it is enzymatically cleaved
to create a new amino terminus at the transmembrane subunit
(Jones and Risser, 1993; Lamb, 1993; Rodriguez et al., 1987;
Rodriguez-Crespo et al., 1995; Wiley and Skehel, 1987). In
addition, they contain a short stretch of sequence, also known
as the fusogenic peptide, crucial for the fusion process in the
membrane-anchored polypeptide chain (Delahunty et al.,
1996; Durrer et al., 1995; Harter et al., 1989; Rapaport and
Shai, 1994; Schaal et al., 1995). Furthermore, it has been
observed that many viral fusion proteins form homotrimers
and contain extended triple-helical coiled coils in their
central cores (Skehel and Wiley, 1998, 2000). This suggests
that the three-stranded coiled-coil architecture is effective at
presenting fusogenic sequences in geometries or conforma-
tions favorable for initiating membrane fusion.
Hemagglutinin (HA), a transmembrane glycoprotein of
the influenza virus, is by far the most studied and best
characterized fusion protein. It plays a critical role in the
entry of virus into the host and is required for membrane
fusion activity. The HA1 subunit mediates binding to cell-
surface sialic acid receptor whereas the HA2 subunit is
critical for expression of fusion activity. Influenza infection
begins when the virus particle binds to the host’s cell-surface
receptor(s), possibly sialic acid-containing glycoproteins or
glycolipids (Skehel and Wiley, 2000; Wiley and Skehel,
1987). Binding of the virus to the cell-surface receptor is
followed by internalization of the entire virus via receptor-
mediated endocytosis. Inside the endosome, the mildly
acidic environment triggers a conformational change in the
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HA that subsequently leads to fusion of the virus envelope
with the endosomal membrane.
Of all membrane fusion proteins, the ectodomain of HA
was the first whose structure was determined to high
resolution. Crystal structures have been determined in
neutral and mildly acidic pHs for proteolytic fragments of
HA, designated BHA and TBHA2, respectively (Bullough
et al., 1994; Wilson et al., 1981). These crystal structures
show that the proteins are organized into homotrimers. The
BHA and TBHA2 fragments are believed to represent the
structure of HA in its native and fusion-active state, re-
spectively. In the BHA, the first 20 amino acids at the N-ter-
minus of HA2, also known as the fusogenic peptide, are
buried inside the core. Based upon these structures, it has
been hypothesized that HA undergoes a conformational
rearrangement when in an acidic environment, resulting in
the exposure and projection of the fusogenic peptides to the
endosomal membrane (Harter et al., 1988, 1989; Pak et al.,
1994). Insertion of the exposed fusogenic peptides into the
target membrane is believed to be a critical step in fusion.
Furthermore, HA does not act in isolation. Ellens et al.
showed that association of several HA trimers at the contact
site is required in the fusion reaction (Ellens et al. 1990).
Similarly, White and co-workers showed that fusion
mediated by the influenza virus hemagglutinin involves the
cooperative action of at least three hemagglutinin trimers
(Danieli et al., 1996). The work of Bentz and of Blumenthal
also supports a similar conclusion (Bentz, 2000; Blumenthal
et al., 1996). It appears that clustering of fusion proteins at
the fusion site serves an important mechanistic role, since
oligomerization of viral fusion proteins has been shown to
correlate with virus-induced fusion (Freed et al., 1992;
Kielian et al., 1996; Wild et al., 1994). It has been proposed
that the fusogenic peptides in the HA trimer would bind the
target membrane in a threefold symmetric configuration
whereas oligomerization of HAs would cause the fusogenic
peptides to associate in the target membrane and participate
as an assembly in the fusion process (Cohen and Melikyan,
2001).
Soluble protein fragments and synthetic peptides have
been widely used as model systems to study the function of
individual fusogenic segments of HA. Epand and co-workers
demonstrated that HA2 fragments containing the N-terminal
fusogenic peptide are capable of inducing vesicle leakage,
lipid mixing, and vesicle aggregation, whereas the kinked
loop (amino acids numbered 91 to 127 in the HA2 subunit)
regulates the pH-dependent fusogenic activities (Epand et al.,
1999; LeDuc et al., 2000). Rafalski et al. showed that the
X31 wild-type peptide, consisting of the first 20 amino acids
at the HA2 N-terminus, exhibits higher levels of phospho-
lipid binding and peptide-induced leakage at mildly acidic
pH than at neutral pH, in the same manner as the full-length
protein (Rafalski et al., 1991). Moreoever, the X31 wild-type
fusogenic peptide has been shown to destabilize lipid
bilayers via pore formation and induce spontaneous lysis
(Longo et al., 1997), although a mutated form of this peptide,
the Ac-E4K, had been shown to destabilize lipid membrane
to failure without stable pore formation at pH below 4.8
(Zhelev et al., 2001). Using the sea urchin bindin B18 and
the designed WAE fusion peptides as model systems, Ulrich
et al. and Pe´cheur et al. showed that fusion occurred
concomitantly with the formation of peptide oligomers in the
membrane-bound state (Pecheur et al., 1999; Ulrich et al.,
1999). However, trimerization or high-order oligomerization
of fusogenic peptides has not been directly observed in
influenza hemagglutinin or other viral fusion proteins.
This study investigates the importance of fusogenic
peptide trimer formation in membrane fusion, using the
fusogenic peptide derived from hemagglutinin of the X31
strain of influenza as a model system. We created a peptide
trimer that incorporates the wild-type X31 fusogenic peptide
at the N-terminus of a VaLd peptide that self-assembles into
a coiled-coil trimer (Ogihara et al., 1997). In this way, the
peptide mimics the low-pH trimer form of the native HA
fusion peptide. We refer to this novel peptide as coiled-coil
X31, or simply ccX31. The membrane interaction properties
of this trimeric peptide were studied at neutral and acidic pH
and compared to the behavior of monomeric X31 wild-type
fusogenic peptide.
MATERIALS AND METHODS
Materials
Amino acids and reagents for peptide synthesis were purchased from
NovaBiochem (Darmstadt, Germany). Solvents for peptide synthesis and
purification were obtained from Fisher Scientific (Hampton, NH). Sodium
acetate, 2-(N-morpholino)ethanesulfonic acid (MES), 3-(N-morpholino)-
propanesulfonic acid (MOPS), N-acety-L-tryptophanamide, dimethylsulf-
oxide (DMSO), sodium chloride, sucrose, and glucose were purchased from
Sigma (St. Louis, MO). The lipids used, 1-stearoyl-2-oleoyl-sn-glycero-
3-phosphatidylcholine (SOPC), N-4-nitrobenzo-2-oxa-1,3-diazole phospha-
tidylethanolamine (NBD-PE), 1-stearoyl-2-oleoyl-sn-glycero-3-(phospho-
L-serine) (SOPS), and N-(Lissamine Rhodamine B sulfonyl)1,2-dioleoyl-
sn-glycero-3-phosphatidylethanolamine (LRh-PE) were obtained from
Avantis Polar-Lipids, Inc (Alabaster, AL). Calcein was purchased from
Lancaster Synthesis (Pelham, NH).
Peptide synthesis and puriﬁcation
The peptides were synthesized using standard solid-phase 9-fluorenylme-
thoxycarbonyl (Fmoc) method on either a Perkin Elmer Applied Biosystems
433A (Foster City, CA) or Milligen 9050 peptide synthesizer (Burlington,
MA). The peptides were assembled on PALTM solid support (Applied
Biosystems, Foster City, CA). Following cleavage from the resin with
trifluoroacetic acid (TFA) with thioanisole, ethanedithiol, and anisole
(90:5:3:2, v/v), the peptides were purified to homogeneity by reverse-phase
HPLC using a Vydac C4 column (22 3 250 mm, 15–20 mm particle size).
The ccX31 peptide was eluted by means of a linear gradient from 41% to
51% of acetonitrile in 0.1% TFA over 36 min. The X31 peptide was purified
using a linear water-acetonitrile/isopropanol/water (3:6:1, v/v) gradient at
0.14% by volume increase per minute of acetonitrile/isopropanol/water
(3:6:1, v/v) in the presence of 0.1% (v/v) TFA. The identities of the peptides
were confirmed by MALDI-TOF mass spectrometry using a Perspective
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Biosystems Voyager DR-RP Biospectrometery Workstation (Applied
Biosystems, Foster City, CA).
Circular dichroism
Stock solution of ccX31 was prepared by dissolving the peptide in deionized
water/methanol (1:1, v/v). The concentration of peptide was determined by
the absorbance at 280 nm in 6 M guanidinium chloride using an extinction
coefficient of 5600 cm1 M1 as the peptide contains one tryptophan.
Aliquots of the stock solution were transferred into 10 mM sodium acetate
and 10 mMMES at pH 5.0, and 10 mMMOPS and 10 mMMES at pH 7.0,
respectively. Spectra were recorded at 258C on an Aviv model 62A DS
circular dichroism spectrophotometer (Aviv Instruments, Lakewood, NJ).
Far UV-spectra were scanned from 195 nm to 260 nm. Data was collected
for every 1-nm interval and averaged for 4 s. Each of the final spectra was the
result of averaging four scans. All spectra were baseline corrected. Mean
residue ellipticities (MRE) were calculated using the equation MRE¼ uobsd/
10lcnwhere uobsd is the ellipticity measured in millidegrees, l is the length of
the cell in centimeters, c is the peptide concentration in moles per liter, and n
is the number of amino acid residues in the peptide. The percent helix
content was calculated from the ellipticity measured at 222 nm, using 0 and
40,000(1  2.5/n) deg cm2dmol1 as the values for 0 and 100% helix,
respectively, where n is the number of amino acid residues (Chakrabartty
et al. 1991).
Sedimentation equilibrium
Sedimentation equilibrium was performed with a Beckman Optima XL-I
analytical ultracentrifuge (Beckman Coulter). The initial peptide concentra-
tion was 30 mM in pH 7.0 and pH 5.0 buffers. The pH 7.0 buffer contained
10 mM MOPS and 10 mM MES, whereas the pH 5.0 buffer contained 10
mM MES and 10 mM sodium acetate, in the presence of 1% (v/v) DMSO.
The samples were centrifuged at 40,000 rpm until equilibrium was reached.
The association state of the peptide was determined by fitting the data to
a single species using the program Igor Pro (WaveMetrics, Lake Oswego,
OR). In the curve fitting, the partial specific volume of the peptide and
density of solution were assumed to be 0.75 and 1.000, respectively.
Binding of peptide to phospholipid bilayers
Our peptides contain a Trp residue at position 14 from the N-terminus that is
highly conserved in all native HA2 sequences. Fluorescence resonance
energy transfer between the tryptophan (donor) and fluorescently labeled
phospholipid (acceptor) was used to characterize the binding of the peptides
with lipid vesicles. Large unilamellar vesicles (LUVs) for this experiment
were prepared by nitrogen stream-evaporation of 25 mg/ml chloroform
solutions of SOPC and 0.25 mg/ml of NBD-PE in a glass centrifugation
tube, followed by hydration in a pH 7.0 buffer (10 mM MES, mM MOPS).
Lipid hydration was coupled with six cycles of freezing, thawing, and
sonication, except sonication was omitted in the last cycle. Finally, the lipid
suspension was extruded five times through a stack of one 1.0 mm and two
0.1-mm pore size polycarbonate filters (Nucleopore Corp., Pleasanton, CA)
in a pressure extruder (Lipex Biomembranes, Vancouver, BC). The total
lipid concentration in the solution was 2 mM, with 1.4 mol percent of NBD-
PE. The vesicles were stored under nitrogen in the dark at ambient
temperature. They were used within 24 h. Small unilamellar vesicles were
prepared by nitrogen stream-evaporation of 10 mg/ml chloroform solutions
of SOPC and 0.25 mg/ml of NBD-PE, followed by redispersion in the pH
7.0 buffer and bath sonication until visual clarity. The total lipid
concentration in the stock solution was 4 mM, with 1.4 mol percent of
NBD-PE. The vesicles were stored under nitrogen in the dark at ambient
temperature before experiments, and they were used within 24 h.
Preliminary lipid binding experiments were conducted using small
unilamellar vesicles at ambient temperature. Fluorescence spectra were
acquired using an SLM 8100 spectrofluorometer (Jobin Yvon, Edison, NJ),
with the excitation wavelength set at 290 nm. Control experiments using
N-acety-L-tryptophanamide as the titrant showed that NBD emission did
not increase during the titration, indicating that freely soluble tryptophan
does not bind to the lipid vesicles. Titration using ccX31 or X31 resulted in
increase in NBD emission, indicating binding of the peptides to the lipid
bilayers. For experiments at pH 5, the pH 7.0 buffer was acidified using 2%
(v/v) acetic acid so that the final concentration of acetic acid was 0.1% (v/v).
To obtain the binding isotherm, LUVs were diluted into the pH 7.0 buffer
and then titrated with stock solutions of either coiled-coil X31 or X31 in
DMSO. In all cases, the final concentration of DMSO was no higher than
2%. Fluorescence spectra were acquired on a PTI QuantaMasterTM C-60
spectrofluorometer (Photon Technology Intenational, Monmouth Junction,
NJ), using excitation wavelength at 290 nm. The emission from 300 nm to
560 nm was recorded for every 1-nm interval. The slit widths of the
excitation and emission monochromators were set at 1 nm. All the ex-
periments were performed at room temperature with constant stirring.
Spectra were corrected for background and dilution. The increase in
emission from NBD (acceptor) indicates binding of the peptides to lipid
vesicles. Acceptor emissions from 500 nm to 560 nm at different total
peptide concentrations were integrated and the ratios of the integrated
intensities relative to the intensity with no peptide added were calculated.
The ratio was plotted against total peptide concentration. Control experi-
ments using DMSO as the titrant were also conducted.
Peptide-induced leakage of liposome contents
The leakage of liposome contents to the external medium was monitored by
the release of calcein encapsulated in lipid vesicles at a self-quenching
concentration. Dilution of calcein relieves self-quenching, leading to
increase in fluorescence. The sodium salt of calcein (40 mM) was
encapsulated in liposomes, buffered with 10 mM MOPS, 10 mM MES,
and 40 mM sodium chloride. The LUVs used in the leakage experiments
were composed of SOPC/SOPS (99:1 mol %). The LUVs were prepared
using the same procedures as described in the lipid binding experiments.
Free calcein outside of the vesicles was removed by gel chromatography on
Sephadex G-25. Vesicles were eluted with buffer containing 10 mM MES,
10 mM MOPS, and 115 mM sodium chloride at pH 7.0. The total lipid
concentration of the eluted LUVs was ;3.0 mM. In the leakage
experiments, aliquots of LUV stock solution were diluted into the elution
buffer so that the final concentration of lipid was;98 mM. Upon addition of
peptides from a DMSO stock solution to the LUV suspension, leakage of
calcein to the external medium was monitored by increase in fluorescence.
Fluorescence measurements for these experiments were done using an SLM-
8100 spectrofluorometer (Jobin Yvon), with the excitation wavelength set at
490 nm. For each run, the increase in fluorescence emission at 520 nm was
followed for 15 min. One hundred percent leakage was established by lysing
the vesicles with 20 mL of 0.1% (w/v) Triton X-100 and the intensity before
addition of peptide was taken as the baseline. Leakage experiment at each
final peptide concentration was repeated for at least three times and the
results averaged. For experiments at pH 5.0, the reaction mixture was
acidified to the desired pH by mixing 1 part of 2% (v/v) acetic acid to 19
parts of pH 7.0 buffer, before the peptide is added. Control experiments
using Coil VaLd and stirring in the absence of peptide were conducted.
Lipid mixing experiments
Our lipid mixing experiments were based on the fusion assay developed by
Struck (Struck et al., 1981). In this work, we used equal concentrations of
unlabeled and labeled vesicles diluted into buffer adjusted to the appropriate
pH, and monitored the change in donor emission as aliquots of peptides were
added to the vesicles. In our experiments, the intensity at 533 nm,
predominantly from the NBD (donor), increases relative to that at 590 nm,
mainly from Lissamine Rhodamine (acceptor) as the mole percentage of
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labeled lipid decreases upon mixing. Three sets of LUV were prepared:
SOPC/SOPS (99:1 mol %), SOPC/SOPS/NBD-PE/LRh-PE (97.8:1:0.6:0.6
mol %), and SOPC/SOPS/NBD-PE/LRh-PE (98.4:1:0.3:0.3 mol %). The
procedures for preparing LUVs were described above in the binding
experiment section. The NBD-PE and LRh-PE were 1 mg/ml chloroform
solutions. The concentration of total lipid in each of the three stock solutions
of LUV was ;12.8 mM. In our experiments, the final lipid concentration
was;200 mM. Lipid mixing experiments at each final peptide concentration
were repeated at least three times and the results averaged. Experimental
data were acquired using either a SLM-8100 spectroflurormeter (Jobin
Yvon) or Aviv ATF-105 spectrofluorometer (Aviv Instruments). The
kinetics of lipid mixing was followed for 15 min. The signal was averaged
for 1 s and sampled every 5 s. In the experiment, zero percent lipid mixing
was defined by the fluorescence intensity before addition of peptide.
Percentage of lipid mixing was normalized to fluorescence emission from
the doubly labeled LUVs, with 0.3 mol % of each fluorophore. For
experiments at pH 5.0, the LUV suspensions were acidified to the desired pH
by mixing 1 part of 2% (v/v) acetic acid to 19 parts of pH 7.0 buffer, before
the peptide was added. Control experiments using coil-VaLd and DMSO
were conducted.
Micropipette aspiration
All sucrose and glucose solutions were prepared with deionized water and
filtered through 0.2 micron filters. Solution osmotic strengths were measured
using a Model 3300 osmometer from Advanced Instruments (Norwood,
MA). Vesicles were prepared by electroformation from SOPC and SOPS.
Ten microliters of 99.5% SOPC, 0.5% SOPS (mol %) in chloroform (0.5
mg/ml) was deposited on platinum electrodes using a Hamilton syringe. The
chloroform was evaporated at room temperature in a vacuum oven for
several hours to leave behind a thin film of lipid. Giant unilamellar vesicles
(GUVs) were then formed in a 100-mM sucrose solution by the electro-
formation method of Angelova et al. (Angelova and Dimitrov, 1986;
Angelova et al., 1992). Although vesicles can also be formed by simple thin
film rehydration, electroformation method was preferred due to a consistent
high yield of GUVs. Micropipettes were made from 1-mm borosilicate glass
capillaries using a Kopf Model 730 Pipette Puller (David Kopf Instruments,
Tujunga, CA). Each pipette was then forged to create a smooth square tip
using a TPI MF-1 microforge (TPI, St. Louis, MO).
Aspiration experiments were performed on a Nikon Diaphot TMD
inverted microscope with Hoffman optics, a custom-made microscope stage
and Narishige Model WR-6 and MMO-203 micromanipulators (Narishige
International USA, East Meadow, NY). In a control chamber containing
glucose buffer, a single lipid vesicle was aspirated with a small suction
pressure to hold it in the pipette. The pressure was increased and then
decreased in a step-wise fashion to gather stress versus strain data for
calculating the area expansion modulus (Ka). The measured values of Ka
give confirmation of single bilayer membrane structure, as well as provide
a baseline for measuring the effect that adsorbed peptide has on the
membrane properties.
After the Ka test, the vesicle was inserted into a much larger transfer
pipette. The microscope stage was translated to bring this two-pipette
assembly into the test chamber. This second chamber contains an
osmotically matched buffer and the test peptide in solution. The vesicle is
removed from inside the protective transfer pipette, thereby marking the t ¼
0 exposure time to the peptide solution. Using Hoffman optics and video
microscopy, the vesicle diameter, projection length, and lysis were
monitored with time and recorded on S-VHS. If lysis did not occur after
a predetermined period of testing time, the Ka test was repeated to gain
a measure of how the adsorbed peptide affected the material properties of the
membrane. During the Ka test, the membrane is stressed until failure, thereby
measuring the critical lysis tension in the presence of the peptide. These
experiments were repeated at pH 5 and pH 7 with three different peptides:
X31, ccX31, and the coiled-coil (‘‘cc’’) domain alone.
Time and pressure data were captured by a custom time code unit built by
R. Waugh and colleagues (University of Rochester, Rochester, NY). These
data and videos of the experiments were recorded on S-VHS using a Sony
SVO-9500MD video recorder. The resulting videotapes were analyzed
using Labview pixel measurement software (National Instruments, Austin,
TX) and custom image analysis routines. These data were then analyzed to
generate plots of projection length versus time, relative area expansion
versus time (a measure of peptide adsorption), as well as whether or not the
peptide caused lysis under the test conditions (Evans and Needham, 1987).
RESULTS
The coiled-coil X31 model system
To test the hypothesis that trimerization enhances the activity
of fusogenic proteins, we have designed and synthesized
a peptide, designated coiled-coil X31 (ccX31), which
mimics the hemagglutinin fusogenic peptide in the acidic
pH environment. It has the sequence: GLFGAIAGFI10ENG-
WEGMIDG20GGEVEALEKK30VAALESKVQA40LEKK-
VEALEH50G. The first 20 amino acids are derived from the
N-terminal residues of influenza hemagglutinin HA2 subunit
of the strain X31F/68, also known as the X31 fusion peptide
or wt-20 peptide. Residues numbered 22–51 come from the
de novo designed coil-VaLd three-helix bundle (‘‘a’’ and
‘‘d’’ positions are underlined). A glycine was inserted
between the coil-VaLd and X31 sequences to serve as
a flexible linker. Our goal is to create a triple-stranded alpha-
helical coiled coil to which the N-terminal fusion peptide is
attached, resembling the structure of viral membrane fusion
ectodomains in their fusion-active state. The peptide was
synthesized and purified as described in Materials and
Methods.
Circular dichroism
Fig. 1 shows the circular dichroism spectra of ccX31
dissolved in aqueous buffers at pH 7.0 and 5.0 conditions.
The spectra indicate that ccX31 has similar helical content in
both pHs, as indicated by the mean residue ellipticities at 208
FIGURE 1 CD spectra of ccX31 in pH 5.0 and pH 7.0 buffers. The
peptide was added from a concentrated stock solution (;4.1 mM in 50%
aqueous methanol) to the buffers to give a final peptide concentration of
53 mM.
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and 222 nm. It also shows that the coil-VaLd trimerization
domain has greatly improved the solubility of the X31
fusogenic sequence so that it can be dissolved in aqueous
solution. The observed signals correspond to ;63% helix.
Since the coil-VaLd region corresponds to about two-thirds
of the length of sequence, it implies the X31 fusogenic
sequence does not adopt a helix even when it is attached to
the coil VaLd peptide.
Sedimentation equilibrium
The oligomerization state of the ccX31 was examined using
sedimentation equilibrium ultracentrifugation. In aqueous
solution at pH 7.0, the peptide associated to form a single
homogeneous species with a molecular weight consistent
with trimer (Fig. 2). At pH 5.0, the peptide formed higher
order aggregates (data not shown).
Peptide binding isotherms
To assess the binding of the peptides to phospholipid
vesicles, we used fluorescence resonant energy transfer. The
X31 sequence contains a Trp residue, which serves as
a fluorescent donor, whereas the LUV contained 1.4 mol %
of NBD as a fluorescent acceptor. Binding of the peptide to
the NBD-labeled vesicles places the two species in proximity
such that excitation of the Trp in the peptide results in an
increase in the emission of the NBD. Fig. 3 illustrates the
change in fluorescence emission (integrated from wave-
length 500 nm to 560 nm) when NBD-labeled LUVs are
titrated with increasing concentrations of X31 and ccX31
peptides at ambient temperature. In all cases, fluorescence
emission increases as the total peptide concentration is
raised. We interpret the increase in fluorescence emission as
the result of energy transfer from the tryptophan (donor) on
the peptides to the NBD (acceptor) on the lipid. Control
experiments using N-acetyl-L-tryptophanamide and DMSO
give no increase in fluorescence, indicating that freely
soluble tryptophan and DMSO do not modulate the NBD
emission. Therefore we conclude that the increase in NBD
emission was the result of partitioning of ccX31 and X31
into lipid bilayers. Our binding studies reveal several major
observations. First, they show that ccX31 and X31 are able
to bind LUVs in both neutral and acidic pH conditions. At
pH 7, the increase in fluorescence is larger for ccX31 than
X31. This suggests that ccX31 binds more tightly to the
vesicle than X31. The higher affinity of ccX31 for lipid can
be explained by ccX31’s larger cooperative binding units
and a smaller loss of entropy upon binding as the fusogenic
sequences are preassociated by the coil-VaLd trimerization
domain. Second, at pH 5, the increase in NBD emission is
smaller for ccX31 than X31 at the same peptide concentra-
tion range. The apparent higher affinity of X31 for lipid in
acidic conditions may be caused by the very low aqueous
solubility of X31 at pH 5.0, which would provide a very
strong driving force for association with vesicles. Third, we
notice that at very low (i.e., a few micromolar) total peptide
concentration the binding isotherms appear unresolved for
both X31 and ccX31 at both pH 7 and pH 5. We rationalize
that a very high lipid-to-peptide ratio favors binding to lipid
vesicles because the large excess of lipid provides many
high-affinity binding sites for the fusogenic peptides. Under
this condition, X31 and ccX31 bind lipid vesicles with
similar affinity.
The binding isotherms obtained under neutral pH
conditions are multiphasic. For X31, the fluorescence
increases linearly with respect to the bulk concentration of
peptide up to ;1 mM, corresponding to a lipid-to-peptide
ratio of 400. Beyond this point, the binding curve is less
FIGURE 2 (Bottom panel) Sedimentation equilibrium analysis of ccX31
in 10 mMMES, 10 mMMOPS at pH 7.0 with 1% (v/v) dimethyl sulfoxide.
The loading concentration of ccX31 was;30 mM. Data collected at 40,000
rpm is shown fitted with trimer species. The top panel shows the residual of
the fit.
FIGURE 3 Titration of ccX31 and X31 peptides with SOPC/NBD-PE
LUV (98.6:1.4 mol %) as monitored by fluorescence. Fluorescence
emissions were measured for LUV at 400 mM in buffer with increasing
amounts of added peptide, and the intensities in the range of 500–560 nm
were integrated. Intensity ratios (F/F0) are plotted where F0 is the integrated
fluorescence intensity measured in the absence of peptide. d, X31 at pH 7; n,
X31 at pH 5; , ccX31 at pH 7; , ccX31 at pH 5.
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steep and appears to saturate near 120 mM. Similarly, for
ccX31, the fluorescence increases linearly with respect to the
bulk concentration of peptide up to ;1 mM, corresponding
to a lipid-to-peptide ratio of 400. Beyond this point again, the
binding curve is less steep and saturation is reached near 100
mM. This observation can be explained using the scaled-
particle approach (Chatelier and Minton, 1996; Minton,
1999; Talbot, 1997; Zuckermann and Heimburg, 2001). This
theory allows for the possibility of multiple interconvertible
surface conformations, such as interfacially adsorbed, in-
serted, and pore-forming aggregates, of the membrane-
bound proteins, with different affinities. As the total peptide
concentration is changed during the titration, the equilibrium
distribution among the various species shifts, leading to
deviation from classical Langmuir isotherm and the
multiphasic appearance of the resulting binding curve.
Therefore, we interpret that the initial phase corresponds to
binding to the high-affinity sites. Next, a second site with
lower affinity for the peptide is populated as the total peptide
concentration is raised. These changes give rise to the ob-
served multiphasic profile.
The binding curves obtained at pH 5, however, resemble
classical binding isotherms. It is possible that the mildly
acidic environment has the effect of increasing the affinities
of the peptide for the low-affinity sites rendering it difficult to
differentiate from the high-affinity binding sites. An alter-
native explanation is that the acidic environment favors
predominantly one surface state. Consequently the binding
isotherms reveal the titration of the major species only.
However, it is not possible to unambiguously identify or
distinguish the formation of different surface conformations
from the changes in fluorescence emission. From the binding
isotherms obtained under our experimental conditions, we
establish the following rank order of apparent affinity of the
peptide for LUV: X31 in acidic pH[ ccX31 in acidic pH[
ccX31 in neutral pH[X31 in neutral pH.
Peptide-induced leakage of liposomal contents
Fig. 4, a–d, illustrate the time course for the release of calcein
from LUVs, induced by the addition of the X31 and ccX31
peptides. In our experiments, both ccX31 and X31 are more
active in acidic pH than neutral pH. However, X31 caused
leakage at pH 5 only, whereas ccX31 causes leakage at both
pH 5 and pH 7. The final extent of leakage increases with
increasing peptide-to-lipid ratio (Fig. 5, a–b). Control ex-
periments using the coil-VaLd peptide, i.e., ccX31 without
the attached fusion peptide, show that it does not destabilize
the vesicles in either acidic or neutral pH (data not shown).
The difference between ccX31 versus X31 is most apparent
in comparison of the activities at pH 7.0, at concentrations
ranging from 0.26 to 2.9 mM. X31 shows no activity whereas
ccX31 is effective in causing leakage. This higher activity is
consistent with the increased binding of ccX31 versus X31.
At pH 5.0, ccX31 was approximately fivefold more active
than X31 despite the fact that ccX31 has a lower apparent
affinity for LUVs. These observations suggest that trimeri-
zation of X31 in the membrane-bound state introduces
‘‘cooperative effect(s)’’ in destabilizing lipid bilayers.
Another notable feature of the leakage experiment is that
the kinetic traces of content leakage appear to level off at
\100% completion, even after a long period of time. Szoka
and co-workers previously observed similar behavior with
the designed GALA peptide (Parente et al., 1990). Their
analysis suggests that GALA-induced leakage occurs as an
all-or-none event and requires the number of peptide
FIGURE 4 Experimental kinetics of calcein release
induced by ccX31 and X31. Various amounts of ccX31
and X31 were added to vesicles containing ;40 mM
encapsulated calcein in the presence of X31 at pH 7.0 (a),
X31 at pH 5.0 (b), ccX31 at pH 7.0 (c), and ccX31 at pH
5.0 (d ). The LUVs were composed of SOPC/SOPS (99:1
mol %). The kinetics of the leakage were followed by
monitoring the increase of the fluorescence intensity at 520
nm and are plotted versus time.
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molecules to exceed certain threshold value. Our results
suggest that the mechanisms of X31- and ccX31-induced
leakage involve the same requirement. An alternative
explanation is that the peptides undergo deactivation as the
reaction proceeds and therefore lose their ability to lyse the
vesicles.
Peptide-induced mixing of lipid bilayers
Fig. 6, a–d, illustrate the mixing of lipid induced by the
peptides as a function of time, as indicated by the increase
in NBD fluorescence. In our experiment, two populations
of vesicles were used, one unlabeled, the other double
fluorescently labeled with NBD (donor) and Lissamine
Rhodamine (acceptor). Peptide-induced mixing of lipid
between these two populations of vesicles will increase the
average distance between donor and acceptor in the fused or
semifused vesicles. This lowers the energy transfer from the
donor to acceptor and leads to an increase in NBD emission.
The results of lipid-mixing experiments revealed a pattern
similar to those of the leakage experiments. First, X31 is only
active at acidic pH, but ccX31 is active at both acidic and
neutral pH conditions. Second, ccX31 appears more potent
in causing lipid mixing when it is in acidic pH conditions
than in neutral pH. Third, both ccX31 and X31 cause
measurable rates of lipid mixing at acidic pH, and the final
extent of lipid mixing increases with increasing peptide
concentration (Fig. 7, a–b). Fourth, at pH 5, ccX31 is more
active than X31. Finally, the extent of lipid mixing seems to
level off at far from complete mixing. Control experiments
using the coil-VaLd peptide show that it is inactive in both
neutral and acidic pHs.
From the binding study, we show that ccX31 and X31
have higher affinities for lipid in acidic pH versus neutral pH.
We argue that this observation partly accounts for their
stronger abilities to induce lipid mixing in acidic conditions.
Similar to the leakage experiment, our data show that, in
acidic pH, ccX31 is more effective than X31 in causing lipid
mixing even though the binding experiments indicate that
ccX31 has a lower affinity for lipid than X31. This suggests
FIGURE 5 Percent calcein leakage from LUV in buffer at 15 min after
addition of X31 (d) and ccX31 () at pH 7.0 (a), and X31 (d) and ccX31 ()
at pH 5.0 (b), as a function of peptide-to-lipid ratio. The LUVs were
composed of SOPC/SOPS (99:1 mol %).
FIGURE 6 Experimental kinetics of lipid mixing in-
duced by ccX31 and X31. Various amounts of ccX31 and
X31 were added to vesicles containing ;40 mM
encapsulated calcein in the presence of X31 at pH 7.0
(a), X31 at pH 5.0 (b), ccX31 at pH 7.0 (c), and ccX31 at
pH 5.0 (d ). The kinetics of the leakage were followed by
monitoring the increase of the fluorescence intensity at 533
nm and are plotted versus time. The unlabeled LUVs and
doubly labeled LUVs were composed of SOPC/SOPS
(99:1 mol %) and SOPC/SOPS/NBD-PE/LRh-PE
(97.8:1:0.6:0.6 mol %), respectively.
278 Lau et al.
Biophysical Journal 86(1) 272–284
that trimerization of fusogenic peptide enhances lipid
mixing. However, it is apparent from the data that the
enhancement of lipid mixing is not as striking as in the
leakage experiment. The extent of lipid mixing induced by
ccX31 at pH 5 is roughly twofold higher than it is at pH 7.
Similarly, ccX31 is about twice as potent as X31 in causing
lipid mixing in pH 5 solutions. Taking into consideration that
ccX31 has a lower affinity for lipid vesicles than X31, as
indicated by the binding isotherm, trimerization introduces
only a small degree of cooperative effect in causing lipid
mixing.
The correlation between leakage and lipid mixing strongly
suggests that lipid mixing involves membrane destabiliza-
tion. Since the peptide-to-lipid ratios in the lipid-mixing
experiments are higher than the corresponding ratios in
leakage experiments, it appears that trimerization of the X31
fusogenic sequence enhances membrane destabilization to
a higher extent than lipid mixing.
Micropipette aspiration
We focus here on the use of micropipette tests that were
developed by Evans and co-workers to measure binding of
ccX31 and X31 to lipid vesicles and monitoring the resulting
changes in mechanical properties of the lipid bilayers, such
as area expansion modulus (Ka) and lysis tension (t). A glass
micropipette was employed to capture and transfer a single
GUV from a control buffer into a similar solution containing
X31 or ccX31 peptide in solution (Fig. 8). Since our
micropipette was connected to a manometer system, the
pipette suction pressure applied to the vesicle could be varied
precisely using micrometer-driven displacement of a water
reservoir. In our setup, the GUVs were suspended in glucose
solutions that had a slightly higher osmolarity than the
sucrose solution inside the vesicles, therefore they were
slightly deflated and had an excess of membrane area
(compared to a sphere of the same volume). Under these
conditions, the apparent area of the vesicle increases when
X31 or ccX31 binds to the vesicle, as indicated by the
increase in projection length of the membrane inside the
micropipette (Fig. 9). The change of surface area (DA) and
membrane tension (t) were determined according to the
relationships (Evans and Needham, 1987; McIntosh et al.,
1995):
FIGURE 7 Percent peptide-induced lipid mixing induced at 15 min after
addition of X31 (d) and ccX31 () at pH 7.0 (a), and X31 (d) and ccX31 ()
at pH 5.0 (b), as a function of peptide-to-lipid ratio. The unlabeled LUVs and
doubly labeled LUVs were composed of SOPC/SOPS (99:1 mol %) and
SOPC/SOPS/NBD-PE/LRh-PE (97.8:1:0.6:0.6 mol %), respectively.
FIGURE 8 (A) Schematic of a transfer pipette experi-
ment. Experiments are conducted in glass chambers on the
stage of an inverted microscope. (B) Photographs of an
SOPC vesicle (i) before exposure to peptide, (ii) increasing
projection length due to peptide adsorption, and (iii) lysing
of vesicle due to peptide.
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DA ¼ 2pRpð1 Rp=RoutÞDL; and
t ¼ DP
2
Rout  Rp
Rout  Rp
 
;
respectively. In the equations, Rout and Rp are the radius of
the vesicle and pipette, respectively, DP is the pipette suction
pressure, and DL is the change in projection length. We
calculated the area expansion, a, using the equation: a ¼
DA/A0 where A0 is the initial surface area. The area
expansion modulus, Ka, can be determined from the slope
of t versus a. In the high-tension regime, Ka is roughly equal
to t/a (McIntosh et al., 1995).
Our micropipette aspiration experiments confirmed that
both ccX31 and X31 are capable of binding to lipid vesicles
at pH 5. From the changes in area expansion, we could
determine that more X31 binds to the vesicles than ccX31 at
pH 5, in agreement with our binding experiments. On aver-
age, X31 caused ;4–6% increase in surface area whereas
ccX31 caused only 2.3% increase in area. At pH 7, ccX31
caused 0.4% increase in surface area whereas X31 caused no
perceptible change in area expansion. Taking all these results
together, the extent of peptide binding for GUVs decrease in
the order: X31 at pH 5[ ccX31 at pH 5[ ccX31 at pH 7[
X31 at pH 7, agreeing with the fluorescence experiments.
Furthermore, the micropipette experiments revealed that
both ccX31 and X31 are capable of perturbing lipid bilayers
at pH 5. Control experiments showed that the coil-VaLd
domain caused no lysis or increase in projection length at
either pH 5 or 7. At pH 7, in the presence of 1 mM ccX31,
;50% of all vesicles tested lysed. No lysis was detected with
X31 at pH 7, even when the peptide concentration was
brought to 10 mM. This is an important observation because
both peptides adsorbed to the vesicles, but only ccX31
caused lysis at pH 7. At pH 5, both X31 and ccX31 caused
lysis of vesicles. However, we should note that the
experiments with ccX31 at pH 5 were done at a concentration
of 1 mM, a 10-fold lower peptide concentration than with
X31 (i.e., 10 mM). In the presence of 10 mM ccX31, lysis of
the GUVs was so fast that determination of other aspects of
peptide-lipid interaction was not possible. Therefore the
ability of the peptide to perturb lipid bilayers decreases in the
order: ccX31 at pH 5[X31 at pH 5[ccX31 at pH 7[X31
at pH 7, agreeing with the fluorescence experiments.
More importantly, the study of single vesicles by micro-
pipette aspiration experiments provides us additional in-
formation and insights into the mechanism by which peptides
disruptmembranes since such data are difficult to obtain using
the bulk experiments. We noticed that exposing a vesicle to
a pH 5 solution containing X31 at 1–10 mM caused the
projection length (L) of the vesicle in the pipette to increase
(Longo et al., 1997). Upon reaching a maximum, the
projection length decreased until lysis occurred and the
vesicle was slowly aspirated into the pipette (Fig. 10). We
interpreted the sequence of events as follows. Binding/
insertion of the peptides into the vesicle increases the total
surface area of the bilayers and therefore the projection length.
Then, during the permeation phase, formation of a stable,
size-selective pore causes diffusion of glucose due to the
chemical potential gradient across the bilayer and cotransport
of water into the vesicle due to osmosis, thereby swelling the
FIGURE 10 Representative projection length (L) versus time data for 10
mM X31 at pH 5 (data courtesy of M. Longo). Note the characteristic shape
of the curve, compared to that of ccX31 (Fig 9 a). First there is an increase in
L as peptide adsorbs and inserts into the membrane, slightly increasing the
apparent surface area of the vesicle. Then, when one or more pores form,
there is a transition to the permeation phase. The vesicle swells as glucose
and water flow into the vesicle and the larger entrapped sucrose cannot flow
out. The projection length decreases as the vesicle swells until failure. This
permeation phase is not seen in the ccX31 data. In the presence of ccX31,
vesicles lyse without the additional strain introduced by swelling, indicating
that ccX31 induces a dramatic drop in the tensile strength of the membrane.
FIGURE 9 Representative aspiration data plots, show-
ing (a) change in projection length (L) versus time and (b)
change in area expansion (a) versus time for 1 mM ccX31
at pH 5. Note that there is no permeation phase before lysis,
which is representative of all experiments with ccX31 at
pH 5. If there was a permeation phase after the initial
adsorption phase, as seen with the X31 peptide (Longo
et al., 1997), then once a pore forms the projection length
would begin to decrease as the vesicle swells until it falls.
Lysis of the vesicle without the additional strain introduced
by swelling indicates that ccX31 induces a dramatic drop in
the tension strength of the membrane. The lipid vesicles are
SOPC/SOPS (99.5:0.5 mol %).
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vesicle. Finally, stretching of the lipid bilayers beyond
a critical value led to failure of the vesicle membrane.
With ccX31, the projection length L increases to a point
and then the vesicle simply lyses, without any apparent
permeation phase. Since the applied tension holding the
vesicle in the pipette does not change, this implies that the
membrane is destabilized to a point that the critical lysis
tension falls below the holding tension. This destabilization
could be local, or isotropic.
To explore this potential difference in the mechanism of
membrane destabilization, we measured the area expansion
modulus (Ka) and lysis tension (tlysis) before and after
exposure of the vesicles to the peptides (Table 1). There was
a notable difference in behavior between ccX31 and X31.
Adsorption of 10 mMX31 decreased Ka at both pH 5 and pH
7, by;40–50% and 20–35%, respectively. Lysis tension did
not decrease at pH 7 after X31 was adsorbed, but it went
down 40–60% at pH 5. This is compatible with the observa-
tion that X31 has a higher affinity for the membrane at pH 5,
and it only causes lysis at pH 5. On the contrary, 1 mM
ccX31 did not show any measurable change in Ka at either
pH (note the 10-fold lower concentration than X31), yet it
reduced the lysis tension by 15–30% at pH 7 and presumably
by an even greater extent at pH 5. In our experiments,
postexposure Ka tests and lysis tension measurements of
ccX31 at pH 5 could not be performed because all of the
vesicles lysed spontaneously under those conditions.
DISCUSSION
The findings of this paper provide new information
concerning fusogenic peptide/phospholipid vesicle interac-
tion and the contribution of the oligomerization domain to
the fusion process. Control experiments using coil-VaLd
demonstrated that it does not bind to or perturb the lipid
bilayers. This finding agrees with our expectation, because
coil-VaLd self-associates in aqueous solution to form a three-
stranded coiled coil, with a transition midpoint of;0.31 mM
(Boice et al., 1996) and solubility in water [20 mg/mL
(Ogihara et al., 1997). Thus, the partitioning of the coil-VaLd
peptide into lipid bilayers should be negligible. Our findings
are consistent with the results reported by Durrer et al. (1996)
that binding of HA to lipid bilayers is mediated through the
fusogenic sequence but not the coiled-coil region of HA and
the observation by Yu et al. (1994) that GCN4 coiled coil
does not interact with lipid vesicles. The lipid binding and
membrane perturbing properties of X31 exhibit a strong
dependence on pH. X31 is fusogenic at acidic pH. At neutral
pH, however, it has a greatly impaired ability to bind lipid,
cause leakage of contents from liposomes, or induce mixing
of lipids. This strong dependence of surface activities on pH
has been previously observed (Lear and DeGrado, 1987;
Longo et al., 1997; Zhelev et al., 2001). We hypothesize that
charge repulsion among Glu11, Glu15, and Asp19 in the X31
will be partially relieved, as they become protonated upon
lowering of pH. The attenuation of charge repulsion will
favor the formation of amphipathic helix and hence increase
the partition at a lipid/water interface. On the other hand,
with ccX31, these properties have much less dependence on
pH. Compared with X31, ccX31 has a significantly higher
level of surface activity at both pH 7 and pH 5. In the
fluorescence and micropipette experiments, we had observed
that the affinity of peptide for lipid decreases in the order:
X31 in acidic pH[ ccX31 in acidic pH[ ccX31 in neutral
pH[X31 in neutral pH. On the other hand, the ability of the
peptides to destabilize lipid bilayers decreases in the order:
ccX31 in acidic pH[ ccX31 in neutral pH[X31 in acidic
pH[X31 in neutral pH. Thus the abilities of the peptides to
disrupt membrane is not a simple consequence of their
binding to bilayers, but instead appears to depend on the
oligomerizatin state of the fusogenic peptides. We argue that
the observed cooperative effect is compatible with defect
formation via aggregation of membrane-bound fusogenic
peptide (Rapaport et al., 1996). If pore formation proceeds
through association of surface-adsorbed peptides in mono-
meric form into aggregates of bound peptides and then into
pores formed by one or more aggregates of bound peptides,
preassociation of the X31 fusogenic peptides (i.e., ccX31)
would favor pore formation that leads to content leakage or
lysis. This would explain the higher level of content leakage
induced by ccX31, i.e., X31 in a trimeric form, despite the
fact that it shares the same fusogenic sequence with X31.
Along the same line of reasoning, this might explain the lack
of activity of X31 in neutral pH, despite the fact that it binds
to the lipid bilayers.
We have shown that the order of surface activities of
ccX31 and X31 measured by fluorescence and micropipette
experiments agree with each other. More importantly, using
micropipette aspiration technique, we are able to study the
interaction of fusogenic peptides with single vesicles and
gain additional insights. A critical finding of this paper is the
correlation of the peptides’ abilities to insert into and de-
stabilize lipid bilayerswith their effects on themechanical pro-
perties on the bilayers. X31 binds to lipid bilayers to a small
extent at pH 7. It causes a moderate decrease (20–30%) in
TABLE 1 Change in area expansion modulus (Ka) and lysis
tension (tlysis) for SOPC vesicles in the presence of X31 and
ccX31 peptides, relative to peptide-free measurements
Percent change
Peptide pH Conc (mM) Ka (mN/m) tlysis (mN/m)
ccX31 5 1 n/a #[60%
ccX31 7 1 n/c # 15–30%
X31 5 5 n/c # 25–40%
X31 5 10 # 40–50% # 40–60%
X31 7 10 # 20–30% n/c
In the absence of peptide, Ka and tlysis for SOPC are 193 mN/m (Evans and
Rawicz, 1990) and 7.0 6 0.4 mN/m (Olbrich et al., 2000; Rawicz et al.,
2000), respectively. n/c ¼ no change; n/a ¼ not available, i.e., all vesicles
lysed spontaneously, so Ka tests were not possible after exposure to peptide.
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the area expansion modulus (Ka) but not the lysis tension
(tlysis). No spontaneous lysis of vesicles was detected in the
micropipette experiments, and no leakage of liposomal
contents or lipid mixing was observed in the bulk. At pH 5,
X31 has a higher affinity for lipid, as determined from the
larger increase in excess surface area (4–6%). It lowers the
Ka and tlysis by 40–50% and 50–60%, respectively. In the
fluorescence experiments, we observed significant amounts
of vesicle leakage and lipid mixing. Also, our fluorescence
experiments indicated that membrane destabilization re-
quires a minimum number of peptides inserted into the
membrane. We attribute the increase in binding and the
resulting membrane destabilization to the conformational
change in the peptide induced by the change in pH (Han
et al., 2001).
The ccX31 peptide does not change the area expansion
modulus (Ka) at either pH 7 or 5. It lowers tlysis by 50% at pH
7 and presumably an even greater amount at pH 5. We
should note that, in the micropipette experiment, all vesicles
lysed spontaneously in the presence of ccX31 at pH 5, so the
lysis tension could not be measured at those conditions.
Because of the spontaneous lysis, we can conclude that the
lysis tension dropped below the small tension applied by the
holding pipette. We have shown that ccX31 does not absorb
to vesicles as much as X31 does at pH 5, as indicated by the
2.3% versus 4–6% increase in surface area, respectively.
Nevertheless, at pH 5, ccX31 causes a greater reduction in
lysis tension and also leads to spontaneous vesicle lysis
characterized by the absence of an interim permeation phase
with stable pores. In the bulk, we observed that ccX31 has
a lower affinity for lipid and yet causes a higher extent of
leakage than X31. In other words, although ccX31 binds less
extensively to the membrane, it nevertheless has a more
dramatic effect on destabilizing the membrane than X31.
Comparing the two peptides, we see that ccX31 causes no
change in area expansion modulus (Ka) at either pH, but it
does dramatically decrease the lysis tension in both neutral
and acidic conditions. In the case of X31, decrease of lysis
tension is linked to decrease in Ka. Taken together with the
fact that a stable permeation phase is not seen with ccX31,
our data suggest that the mechanisms for membrane failure
are different for X31 and ccX31. In the case of X31, the
understanding is that pores form (either transient or stable)
that allow the flux of glucose into the vesicle at a more rapid
rate than the efflux of the encapsulated sucrose. Therefore,
water flows into the vesicles to equalize the osmotic
pressure. This causes the vesicles to swell, visualized by
decreasing projection length in the pipette. When the vesicles
swell to a point where the membrane tension is greater than
the lysis tension of the membrane, the vesicles break. Further
experiments could provide insight into the approximate size
of the pores formed by substituting larger solutes for glucose
until the swelling behavior can no longer be observed. By
comparison, the ccX31 vesicles spontaneously fail without
a detectable permeation phase. It appears that ccX31 peptide
causes a decrease in the stability of the membrane, such that
the low holding tension of the pipette causes the vesicles to
lyse. We know from the binding studies that, at pH 5, ccX31
binds to the bilayers to a lesser extent but destabilizes the
bilayers to a larger extent than X31. Since ccX31 lowers the
tlysis (lysis tension) without affecting the Ka (area expansion
modulus), it appears that ccX31 does not weaken the lipid-
lipid interaction on the more global scale. That is, the
formation of defect is occurring only at one local part of
the membrane, instead of many sites all over the surface
of vesicles. Therefore, we hypothesize that trimerization of
fusogenic peptides, and possibly also formation of higher
order aggregates of the ccX31, in the membrane-bound state
creates localized defects that cause the membrane to fail
because the membrane cannot support the defect formed by
the peptide. Thus it causes point defects, rather than an
isotopic weakening of the membrane. The importance of
protein oligomerization, at the level of the whole protien and
fusogenic peptide, in the fusion process had been shown for
other viral fusion proteins. Our results here are consistent
with these studies (Freed et al., 1992; Kielian et al., 1996;
Markovic et al., 1998; Pecheur et al., 1999; Ulrich et al.,
1999; Wild et al., 1994). More importantly, it suggests
a functional role for the oligomerization of fusogenic
peptides in the fusion mechanism. Previously, Yu et al.
(1994) reported membrane insertion by the HA coiled-coil
peptide and proposed a role for the HA coiled-coil domain in
facilitating membrane fusion. Future experiments will be
directed to investigate the origin of enhancement of
fusogenic activities caused by the coiled coil domain. For
instance, we might replace the fusogenic sequence in the
ccX31 with known fusion-incompetent mutants, and study
their fusogenic properties. Also, we would examine the
conformational change of ccX31 upon lipid binding by
circular dichroism spectroscopy.
CONCLUSION
In this project, we have demonstrated a consistent pattern of
enhanced surface activity for ccX31 over X31. The strong
correlation between leakage and lipid mixing strongly
indicates that both reactions involve membrane destabiliza-
tion. Our results are consistent with the hypothesis that
oligomerization of fusogenic peptides promotes membrane
fusion by facilitating membrane destabilization. It also sheds
light onto the biological advantages of having the viral
proteins responsible for membrane fusion in oligomeric
forms. In addition, analysis of micropipette aspiration data
suggest that oligomerization of fusogenic peptides promotes
localized membrane instability. This offers the advantage of
restricting perturbation to the contact site, therefore mini-
mizing potential damage to the host. However, ccX31
appears to enhance leakage to a greater extent than lipid
mixing, implying that lipid mixing involves other segments
of the HA or processes besides membrane destabilization.
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This also implies other regions in the HA should play
important roles in promoting the fusion. Our techniques,
however, do not allow us to resolve the interaction between
the fusogenic peptide and the bilayers at the molecular level.
Structural studies using electron microscopy would provide
valuable information on that aspect. We have also pointed
out in the previous sections that the transmembrane domain
of viral fusion proteins is potentially important in the final
step of the fusion process. In the future, the contribution of
the transmembrane domain would be probed.
This work is supported by National Institutes of Health grant GM-54616.
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